Insider Cluster (2 insiders) ·Filed Jun 15, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $239K total
Actionable Insight • Neutral

This insider cluster is routine and non-informative. The sales are de minimis relative to market cap and are mechanically tied to large option exercises. Monitor the company's next 10-Q for any changes in business fundamentals, but there is no actionable trading signal from this filing.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
UTHR ▼ -8.10% at T+60d
NEUTRAL call ✗ call lost -8.10% · α vs SPY -9.10% · entry $548.27 → $503.86
Entry anchored
Jun 15, 03:59 PM ET
via exchange tick
T+1d
+0.58%
call +0.58% · α +1.83%
$551.47
settled 4mo ago
T+5d
-0.72%
call -0.72% · α +1.51%
$544.33
settled 3mo ago
T+20d
-3.94%
call -3.94% · α -4.14%
$526.66
settled 3mo ago
T+60d
-8.10%
call -8.10% · α -9.10%
$503.86
settled 22d ago

Price Chart

Loading chart...

Executive Summary

UTHR CEO and CFO sold shares totaling $239K in open-market transactions over a two-day window, alongside routine option exercises. The sales represent a trivial ~0.001% of the company's $23.2B market cap and are consistent with typical tax-withholding / plan diversification following derivative exercises. No material information signal.

Key Financial Metrics

Direction
selling
Total Value
$239.0K
Insiders
2

Key Facts

  • CEO (Chairperson & CEO) sold 399 shares at $537.40 for $214K on 2026-06-12.
  • CFO (CFO AND TREASURER) sold 46 shares at $542.94 for $25K on 2026-06-11.
  • Both insiders also exercised large tranches of stock options (non-cash and cash exercises) totaling millions of dollars in notional value — typical for vesting/settlement.
  • Total open-market sale value: ~$239K, which is <0.01% of UTHR's $23.2B market cap.
  • No open-market purchases in the cluster; all sales are paired with derivative exercises, consistent with tax-planning/10b5-1 routine patterns.

Financial Impact

Total insider open-market sales of ~$239K, negligible relative to $23.2B market cap

insider holdingsdilution

Risk Factors

  • No elevated risk identified from this insider activity alone.
  • CEO and CFO each continue to hold substantial equity stakes after these sales.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1781555800016
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 15, 2026